VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 79 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,400 | -60.4% | 33,600 | -41.5% | 0.00% | -50.0% |
| Q2 2023 | $657,173 | +227.8% | 57,395 | +120.8% | 0.00% | +100.0% |
| Q1 2023 | $200,460 | +1.2% | 26,000 | -22.2% | 0.00% | 0.0% |
| Q2 2022 | $198,000 | -73.1% | 33,427 | -65.3% | 0.00% | -50.0% |
| Q1 2022 | $735,000 | +1212.5% | 96,457 | +616.7% | 0.00% | – |
| Q2 2021 | $56,000 | -96.4% | 13,459 | -95.9% | 0.00% | -100.0% |
| Q1 2021 | $1,540,000 | +53.5% | 326,994 | +354.8% | 0.00% | +33.3% |
| Q4 2019 | $1,003,000 | -23.3% | 71,897 | -5.3% | 0.00% | -25.0% |
| Q3 2019 | $1,307,000 | +0.9% | 75,930 | +59.5% | 0.00% | 0.0% |
| Q2 2019 | $1,295,000 | -2.0% | 47,591 | -66.1% | 0.00% | -20.0% |
| Q4 2018 | $1,321,000 | -18.3% | 140,536 | +64.4% | 0.01% | +25.0% |
| Q3 2018 | $1,617,000 | -51.6% | 85,481 | -50.0% | 0.00% | -60.0% |
| Q2 2018 | $3,338,000 | +939.9% | 170,817 | +898.9% | 0.01% | +900.0% |
| Q1 2018 | $321,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
| ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
| SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
| GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
| Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
| Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
| Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
| Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |